InMode Ltd (NAS:INMD)

$ 17.02 -0.28 (-1.62%) Market Cap: 1.32 Bil Enterprise Value: 621.24 Mil PE Ratio: 9.16 PB Ratio: 1.75 GF Score: 85/100

Q3 2024 Inmode Ltd Earnings Call Transcript
Oct 30, 2024

$17.87 (-0.22%)

Earnings
Q2 2024 Inmode Ltd Earnings Call Transcript
Aug 01, 2024

$16.57 (-8.55%)

Earnings
Q1 2024 Inmode Ltd Earnings Call Transcript
May 02, 2024

$17.36 (+0.70%)

Earnings
Q4 2023 Inmode Ltd Earnings Call Transcript
Feb 13, 2024

$23.67 (-10.65%)

Earnings
Q3 2023 Inmode Ltd Earnings Call Transcript
Nov 02, 2023

$21.76 (+14.35%)

Earnings
Inmode Ltd at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 15, 2023
Inmode Ltd at Canaccord Genuity Growth Conference Transcript
Aug 09, 2023
Q2 2023 Inmode Ltd Earnings Call Transcript
Jul 27, 2023

$44.06 (-2.15%)

Earnings
Q1 2023 Inmode Ltd Earnings Call Transcript
May 02, 2023

$33.83 (-10.00%)

Earnings
Inmode Ltd at Barclays Global Healthcare Conference Transcript
Mar 15, 2023
Q4 2022 Inmode Ltd Earnings Call Transcript
Feb 14, 2023

$37.57 (+10.50%)

Earnings
Q3 2022 Inmode Ltd Earnings Call Transcript
Oct 27, 2022

$36.18 (+5.11%)

Earnings
Inmode Ltd at Robert W Baird Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Inmode Ltd Earnings Call Transcript
Jul 28, 2022

$33.35 (+13.90%)

Earnings
Q1 2022 Inmode Ltd Earnings Call Transcript
May 02, 2022

$25.61 (+1.99%)

Earnings
Inmode Ltd at Barclays Global Healthcare Conference Transcript
Mar 17, 2022
Q4 2021 Inmode Ltd Earnings Call Transcript
Feb 10, 2022

$51.34 (-4.16%)

Earnings
Q3 2021 Inmode Ltd Earnings Call Transcript
Oct 26, 2021

$87.51 (+0.08%)

Earnings
Inmode Ltd at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Aug 12, 2021
Q2 2021 Inmode Ltd Earnings Call Transcript
Jul 28, 2021

$55.37 (+1.73%)

Earnings
Inmode Ltd at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2021
Inmode Ltd at UBS Global Healthcare Virtual Conference Transcript
May 26, 2021
Q1 2021 Inmode Ltd Earnings Call Transcript
May 05, 2021

$40.6 (-3.51%)

Earnings
Q4 2020 Inmode Ltd Earnings Call Transcript
Feb 10, 2021

$34.84 (+1.25%)

Earnings
Q3 2020 Inmode Ltd Earnings Call Transcript
Nov 12, 2020

$20.45 (-6.19%)

Earnings
Inmode Ltd at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript
Aug 13, 2020
Q2 2020 Inmode Ltd Earnings Call Transcript
Aug 05, 2020

$16.17 (-1.79%)

Earnings
Inmode Ltd at UBS Global Healthcare Conference (Virtual) Transcript
May 18, 2020
Q1 2020 Inmode Ltd Earnings Call Transcript
May 06, 2020

$12.5 (-3.88%)

Earnings
Inmode Ltd at Barclays Global Healthcare Conference Transcript
Mar 11, 2020
Q4 2019 Inmode Ltd Earnings Call Transcript
Feb 18, 2020

$20.35 (-7.44%)

Earnings
Q3 2019 Inmode Ltd Earnings Call Transcript
Nov 05, 2019

$20.33 (+19.69%)

Earnings

Inmode Ltd at Canaccord Genuity Growth Conference Transcript

Aug 09, 2023 / 04:30PM GMT

Release Date Price: $42.2 (-2.22%)

Transcript

Caitlin Cronin

Canaccord Genuity Group Inc. - Analyst

And thank you for joining us at this year's Canaccord Genuity Growth Conference. My name is Caitlin Cronin, and I'm one of the medical device analysts here at Canaccord Genuity. Joining us this afternoon is InMode, a leading player in the global energy-based aesthetics treatment market. With me today is Yair Malca, CFO; and Dr. Spero Theodorou, CMO.

We're going to start off with a brief presentation followed by some Q&A. And before we begin, I want to remind everyone of any relevant disclosures, which can be found on our conference and firm website. With that, I'll turn it over to InMode.

Yair Malca

InMode Ltd. - CFO

Thank you, Caitlin. Thanks for having us. We think the best way would be to start with a short video, six minutes, with an overview of our existing technologies, as well as the future products and where we are heading from here. And then we'll be very pleased to take some Q&A. Go ahead with the video, please.

(video playing)

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.